Details for 2022181403
Up to date per 04.04.2026
Actions
Details for 2022181403
Granted/Registered
European Patent
10.05.2023 A
28.02.2024 B1
10.01.2014
US
201461926226 P
02.05.2014
US
201461988104 P
A61K 38/36 20060101AFI20230327BHEP
Owner
Bioverativ Therapeutics Inc.225 Second Avenue Waltham MA 02451US
Representative
No representatives present
Inventor
CHHABRA, Ekta, Seth Framingham, MA 01702US
LIU, Tongyao Lexington, MA 02421US
PETERS, Robert T. Needham, MA 02492US
KULMAN, John Belmont, MA 02748US
Information about Fees